Atrial natriuretic peptide and related peptides

Yoshihiro J. Akashi; Jochen Springer; Mitja Lainscak; Stefan D. Anker

doi:10.1515/CCLM.2007.274

Atrial natriuretic peptide and related peptides

Yoshihiro J. Akashi, Jochen Springer, Mitja Lainscak, Stefan D. Anker

Research output: Contribution to journal › Article

29 Citations (Scopus)

Abstract

In recent years, biomarkers have been recognized as important tools for diagnosis, risk stratification, and therapeutic decision-making in cardiovascular diseases. Currently, the clinical potential of several natriuretic peptides is under scientific investigation. The well-known counter-regulatory hormones are atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), dendroaspis natriuretic peptide (DNP) and urodilatin, which play an important role in the homeostasis of body fluid volume. ANP and BNP have already been demonstrated to have diagnostic usefulness in a great number of studies, which have progressed from bench to bedside. This article summarizes existing data on ANP and related peptides in cardiovascular and other disorders, and outlines the potential clinical usefulness of these markers.

Original language	English
Pages (from-to)	1259-1267
Number of pages	9
Journal	Clinical Chemistry and Laboratory Medicine
Volume	45
Issue number	10
DOIs	https://doi.org/10.1515/CCLM.2007.274
Publication status	Published - Oct 2007

Access to Document

10.1515/CCLM.2007.274

Cite this

@article{e587cf52513344bfa4b9ff02480d4328,

title = "Atrial natriuretic peptide and related peptides",

abstract = "In recent years, biomarkers have been recognized as important tools for diagnosis, risk stratification, and therapeutic decision-making in cardiovascular diseases. Currently, the clinical potential of several natriuretic peptides is under scientific investigation. The well-known counter-regulatory hormones are atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), dendroaspis natriuretic peptide (DNP) and urodilatin, which play an important role in the homeostasis of body fluid volume. ANP and BNP have already been demonstrated to have diagnostic usefulness in a great number of studies, which have progressed from bench to bedside. This article summarizes existing data on ANP and related peptides in cardiovascular and other disorders, and outlines the potential clinical usefulness of these markers.",

author = "Akashi, {Yoshihiro J.} and Jochen Springer and Mitja Lainscak and Anker, {Stefan D.}",

year = "2007",

month = oct,

doi = "10.1515/CCLM.2007.274",

language = "English",

volume = "45",

pages = "1259--1267",

journal = "Clinical Chemistry and Laboratory Medicine",

issn = "1434-6621",

publisher = "Walter de Gruyter",

number = "10",

}

TY - JOUR

T1 - Atrial natriuretic peptide and related peptides

AU - Akashi, Yoshihiro J.

AU - Springer, Jochen

AU - Lainscak, Mitja

AU - Anker, Stefan D.

PY - 2007/10

Y1 - 2007/10

N2 - In recent years, biomarkers have been recognized as important tools for diagnosis, risk stratification, and therapeutic decision-making in cardiovascular diseases. Currently, the clinical potential of several natriuretic peptides is under scientific investigation. The well-known counter-regulatory hormones are atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), dendroaspis natriuretic peptide (DNP) and urodilatin, which play an important role in the homeostasis of body fluid volume. ANP and BNP have already been demonstrated to have diagnostic usefulness in a great number of studies, which have progressed from bench to bedside. This article summarizes existing data on ANP and related peptides in cardiovascular and other disorders, and outlines the potential clinical usefulness of these markers.

AB - In recent years, biomarkers have been recognized as important tools for diagnosis, risk stratification, and therapeutic decision-making in cardiovascular diseases. Currently, the clinical potential of several natriuretic peptides is under scientific investigation. The well-known counter-regulatory hormones are atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), dendroaspis natriuretic peptide (DNP) and urodilatin, which play an important role in the homeostasis of body fluid volume. ANP and BNP have already been demonstrated to have diagnostic usefulness in a great number of studies, which have progressed from bench to bedside. This article summarizes existing data on ANP and related peptides in cardiovascular and other disorders, and outlines the potential clinical usefulness of these markers.

U2 - 10.1515/CCLM.2007.274

DO - 10.1515/CCLM.2007.274

M3 - Article

VL - 45

SP - 1259

EP - 1267

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 10

ER -